ISIN:DE0005313704

ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions

  Showcasing at AAO 2024: * ZEISS VisioGen offers a cutting-edge, AI-driven solution designed to enhance refractive patient communication and streamline clinic operations. * ZEISS Milestone: Celebrating more than 10 million eyes treated with lenticule extraction solutions utilizing ZEISS SMIL...

2024-10-09 21:00 1888

ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens removal device, available in the U.S.

The ZEISS MICOR 700 uses the ZEISS NULEX (non-ultrasonic lens extraction) procedure to help surgeons broaden their intraocular working space, minimizing risk to surrounding eye structures and increasing operating room efficiency. DUBLIN, Calif. and JENA, Germany, Sept. 26, 2024 /PRNewswire/ -- ZE...

2024-09-26 21:00 1443

ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow

Showcasing at EURETINA 2024: ZEISS will highlight new surgical innovations and artificial intelligence (AI) tools for retinal patient care, helping doctors diagnose and treat patients efficiently and effectively:  * THE FUTURE OF VITREORETINAL SURGERY: Demonstrating the ZEISS ARTEVO 850 3D dig...

2024-09-12 20:00 1753

ZEISS innovation paves way to more personalized patient care with cutting-edge AI technology and industry-leading surgical solutions

Showcasing at ESCRS from Sept. 6 to 10, in Barcelona, Spain:  REFRACTIVE INDUSTRY MILESTONES: ZEISS extends its global refractive industry momentum with more than 10 million eyes treated with ZEISS SMILE and ZEISS SMILE pro; ZEISS announces first treatment in the CE market for hyperopia with len...

2024-08-29 20:00 1656

ZEISS announces OCT technology enhancements to better support growing era of data-driven patient care

ZEISS Medical Ecosystem fortifies the CIRRUS 6000 with the U.S. market's largest OCT reference database and advanced cybersecurity features. DUBLIN, Calif., May 30, 2024 /PRNewswire/ -- ZEISS Medical Technology announced today that the CIRRUS® 6000 from ZEISS now enables a highly efficient and d...

2024-05-30 21:00 1816

Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market

ZEISS secures regulatory approvals to acquire D.O.R.C.; companies now shift focus to integration implementation, fueling world-class innovation, and driving market expansion strategy for ophthalmic medical devices and surgery.   JENA, Germany and DUBLIN, Calif., April 4, 2024 /PRNewswire/ -- Carl...

2024-04-04 19:00 4040

ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024

* Product News: ZEISS announces enhanced visualization capabilities with the new ZEISS ARTEVO 850 3D heads-up ophthalmic microscope. * Spatial Computing Innovation: ZEISS will demonstrate a digital application for experiencing 3D videos and more on the Apple Vision Pro. * Workflow Innovati...

2024-03-28 21:00 2209

U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS

The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements. DUBLIN, Calif. and JENA, Germany, Jan. 11, 2024 /PRNewswire/ -- Carl Zeiss Meditec AG -- ZEISS Medical Technology announced today that the U.S. ...

2024-01-11 20:00 1974

Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)

Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment JENA, Germany, Dec. 16, 2023 /PRNewswire/ -- Carl Zeiss Meditec AG announced today that it has entered into an agreement to acquire 100% of the shar...

2023-12-16 03:20 6116

ZEISS Announces U.S. FDA Approval of the CT LUCIA 621P Monofocal IOL, Offering the Unique ZEISS Optic to the U.S. Market

The monofocal IOL enables surgeons to treat a wide range of cataract patients while supporting optimized visual outcomes. JENA, Germany and DUBLIN, Calif., April 25, 2023 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) has approved theCT LUCI...

2023-04-25 21:00 2019

ZEISS to Unveil Clinical Insights Supporting the Value of New Data-Driven Digital Workflow Solutions and Software Applications

Advancing ophthalmic care through integrated clinical workflow solutions: * Efficiency in the cataract workflow * Can help increase treatment outcome predictability in the corneal refractive workflow * Machine learning and artificial intelligence in the retina clinic JENA, Germany and DUBLI...

2022-04-06 21:00 2188

ZEISS Introduces a Series of Major Innovations and Industry-First Software Applications as Part of the ZEISS Medical Ecosystem

A fully connected and integrated approach keeps ZEISS at the forefront of ophthalmology with new data management innovations across devices, workflow solutions and software applications. JENA, Germany and DUBLIN, Calif., Sept. 20, 2021 /PRNewswire/ -- At ZEISS Innovation Week,September 21- 23, 2...

2021-09-20 22:00 2357

ZEISS Introduces the Fully Integrated, Data-Driven Medical Ecosystem

JENA, Germany and DUBLIN, Calif., July 13, 2021 /PRNewswire/ -- ZEISS today announced its newZEISS Medical Ecosystem, a fully integrated environment where a combination of devices, data management, applications and services drive continuous improvement of patient outcomes. This ecosystem distinct...

2021-07-13 22:00 2164

ZEISS at the 2020 Virtual ESCRS & EURETINA Congress

ZEISS Introduces New Solution Enhancements for Procedure Workflows at ESCRS and EURETINA JENA, Germany, Oct. 2, 2020 /PRNewswire/ -- ZEISS presents its new solution enhancements to help doctors maximize clinical efficiency and improve patient care - from assessment, diagnosis, to treatment. The ...

2020-10-02 03:16 3632

ZEISS Medical Technology Announces Changes in Ophthalmic Devices Executive Leadership

JENA, Germany, March 9, 2020 /PRNewswire/ -- Carl Zeiss Meditec AG      * Jim Mazzo, current President of Ophthalmic Devices and Head of Ophthalmic Devices Strategic Business Unit for ZEISS will retire from ZEISS effective1 May 2020 and will continue to support ZEISS as an advisor * Dr. Eua...

2020-03-09 21:30 1661

ZEISS to showcase advancements in digital and surgical technology at ESCRS 2019

New digital and industry first solutions from ZEISS will be presented at the European Society of Cataract and Refractive Surgery (ESCRS) fromSeptember 14 - 18, 2019 PARIS, Sept. 14, 2019 /PRNewswire/ -- During the 2019 European Society of Cataract and Refractive Surgery (ESCRS) Annual Meeting in...

2019-09-14 13:00 3029

ZEISS Showcases New CIRRUS 6000 OCT System at the European Society of Retina Specialists 2019 Congress

The ZEISS CIRRUS 6000, 100kHz OCT system promises to dramatically elevate the efficiency of eye care practices.  PARIS, Sept. 5, 2019 /PRNewswire/ -- ZEISS Medical Technology Segment expands its *CIRRUS® — the most trusted Optical Coherence Tomography (OCT) with the launch of its new CIRRUS 600...

2019-09-05 14:00 2121

ZEISS unveils next generation of ophthalmic laser VISULAS green at World Ophthalmology Congress

VISULAS® green, the next generation of photocoagulation laser from ZEISS allows doctors to fully concentrate on the patient's treatment procedure without interruption.   BARCELONA, Spain, June 16, 2018 /PRNewswire/ -- Today, the Medical Technology business group of ZEISS unveiled its next-genera...

2018-06-16 14:00 3013

Week's Top Stories